South Dakota State University
Brookings, South Dakota, 57007, United States
NCT Number: NCT03454347
Following orthopedic surgery and/or injury, a significant loss of muscle mass is generally observed. While this loss of muscle mass appears to be the norm, it causes significant problems in both the athletic and general population. Athletes struggle to regain their performance because of the decrease in muscle mass and also have a greater potential for reinjury while they are in a depleted state. In the general population, and particularly among the elderly, this loss in muscle mass can be even more devastating because as people age, it is more difficult to regain muscle after it is lost. In elderly individuals, this loss in muscle mass can lead to significant disability, diminished quality of life along with an increased risk of falls. In addition to the muscle mass lost during the post-operative period, the strength of the muscle also decreases. This has obvious performance implications in athletes, as well as having the potential to extend recovery time. In the elderly, decreased strength may result in reduced independence and inability to perform activities of daily living. Many previous bed rest studies have reported that significant bone loss also occurs during times of decreased mechanical loading. The post-operative period generally results in decreased mechanical loading; however, some muscle loading will still occur during the rehabilitation process. The dynamic relation between muscle activity/loading and bone density changes in the post-operative state has not been fully described and requires further study.
With this knowledge of the importance of nutrition to the musculoskeletal system, applying the principles of increased protein intake through the addition of a dietary supplement to a population preparing for orthopedic surgery and subsequent muscle disuse is a logical next step. The investigators hypothesize that through the consumption of a protein-based dietary supplement three times per day (75g protein), along with educating patients on the importance of consuming foods that are high in protein, there will be an attenuation of decreases in muscle mass and strength as well as losses in bone that occur with orthopedic injury and disuse. The investigators long-term goal is to identify a nutritional protocol that can be implemented prior to and following orthopedic surgery to diminish the deleterious effects of the subsequent disuse on muscle and bone.
Looking for future studies?
Notify Me18 year–25 year
All sexes
Interventional
Not applicable
Brookings, South Dakota, 57007, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The dietary supplement includes 1.5 grams of fat, 19 grams of carbohydrate, and 25 grams of protein per serving. Participants in the experimental group will consume 3 servings per day.
This group will complete two weeks of lower limb suspension.
Time frame: Measurements will be obtained prior to immediately following 2 weeks of lower limb suspension
Whole body muscle mass (kg) will be measured using DXA while muscle cross-sectional area of the lower leg will be measured via pQCT
Time frame: Measurements will be obtained prior to immediately following 2 weeks of lower limb suspension
Torque production (NM) will be measured using isokinetic testing with a Biodex System 4 Ergometer. The protocol will include maximal quadricep extension and hamstring flexion performed at 60, 180, and 300 degrees per second
Time frame: Measurements will be obtained prior to immediately following 2 weeks of lower limb suspension
Volumetric bone mineral density (mg/cm^2) at the 66% slice of the tibia will be measured using pQCT
Time frame: Measurements will be obtained prior to immediately following 2 weeks of lower limb suspension
Total bone cross sectional area (cm^2) at the 66% slice of the tibia will be measured
South Dakota State University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06205784
Atrophy, Disuse Atrophy
Copenhagen, Capital Region, Denmark
View Trial DetailsNCT06228742
Atrophy, Atrophy, Disuse
Natick, Massachusetts, United States
View Trial DetailsNCT04422665
Atrophy, Disuse Atrophy
Edgbaston, West Midlands, United Kingdom
View Trial DetailsNCT02109380
Disuse Atrophy, Muscular Diseases
Maastricht, Netherlands
View Trial Details